Biogen International GmbH

At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases.

Neuhofstrasse 30, 6340 Baar, Switzerland

You may also be interested in

ACTHERA is a Swiss biotech company and is the result of over 10 years of academic research & development in the universities of Basel, Fribourg and Texas Dallas (USA). The therapeutic platform is based on Hard-Shelled Liposomes (HSLs) that can contain a broad variety of therapeutically active ingredients. ACTHERA’s unique and highly innovative release mechanism will allow the release of active ingredients at therapeutic sites, thus revealing an extraordinarily wide field of applications to transform numerous therapeutic areas.
4052 Basel

Perseo pharma: best-in-class enzyme therapeutics Perseo pharma is a preclinical-stage biotech start-up developing best-in-class enzyme therapeutics based on an innovative proprietary nanotechnology platform.
4057 Basel

OM Pharma is a global Geneva-based Biotech company. It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases. It operates worldwide through a strong network of international partners and continues to invest into R&D to develop microbial derived immunotherapeutic products addressing acute and chronic immunological disorders resulting from infections and inflammation. OM Pharma is operating to highest Good Manufacturing Practice (GMP) standards which rely on a high level of Biotech competencies and experienced teams. The company strives to help patients around the world to live better lives by allowing access to a better management of infectious diseases and immunological imbalances.
1217 Meyrin